Literature DB >> 11331090

The question of PANDAS in adults.

S M Bodner1, S A Morshed, B S Peterson.   

Abstract

BACKGROUND: Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) are a well-defined cause of obsessive-compulsive disorder in children. However, they have not been described or fully investigated in adults newly diagnosed with obsessive-compulsive disorder.
METHODS: We describe an adult with onset of obsessive-compulsive disorder at 25 years of age after a severe antibiotic-responsive pharyngitis. He was evaluated with multiple psychiatric rating scales for obsessive-compulsive disorder and Tourette's syndrome, as well as with serologic assays and radiologic studies.
RESULTS: In all respects except age our patient fulfilled established criteria for PANDAS. Assays for antibodies to group A beta-hematolytic streptococci, serum D8,17 lymphocytes, antistriatal (neuronal) antibodies, and anticytoskeletal antibodies all supported the hypothesis that a poststreptococcal process was active. Magnetic resonance imaging was abnormal and is described.
CONCLUSIONS: The findings suggest that this patient's illness is similar to PANDAS in presentation and that poststreptococcal disease may result in adult-onset obsessive-compulsive disorder.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331090     DOI: 10.1016/s0006-3223(00)01127-6

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  12 in total

1.  Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infection (PANDAS): a Controversial Diagnosis.

Authors:  Sheila Knupp Feitosa de Oliveira; Christina Feitosa Pelajo
Journal:  Curr Infect Dis Rep       Date:  2010-03       Impact factor: 3.725

2.  [Therapy-resistant depression with fatigue. A case of presumed streptococcal-associated autoimmune disorder].

Authors:  K Bechter; A Bindl; M Horn; V Schreiner
Journal:  Nervenarzt       Date:  2007-03       Impact factor: 1.214

3.  Sore throat and obsessions: A causal link?

Authors:  Chittaranjan Andrade; N Pfizer
Journal:  Indian J Psychiatry       Date:  2006-04       Impact factor: 1.759

4.  A preliminary study of the frequency of anti-basal ganglia antibodies and streptococcal infection in attention deficit/hyperactivity disorder.

Authors:  Rocio Sanchez-Carpintero; Sergio Aguilera Albesa; Nerea Crespo; Pablo Villoslada; Juan Narbona
Journal:  J Neurol       Date:  2009-03-14       Impact factor: 4.849

5.  Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.

Authors:  Harry S Courtney; David L Hasty; James B Dale
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

Review 6.  Tourette's syndrome: clinical features, pathophysiology, and therapeutic approaches.

Authors:  Norbert Müller
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

7.  Lyme disease and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): an overview.

Authors:  Hanna Rhee; Daniel J Cameron
Journal:  Int J Gen Med       Date:  2012-02-22

8.  Obsessive-compulsive disorder and trichotillomania: a phenomenological comparison.

Authors:  Christine Lochner; Soraya Seedat; Pieter L du Toit; Daniel G Nel; Dana J H Niehaus; Robin Sandler; Dan J Stein
Journal:  BMC Psychiatry       Date:  2005-01-13       Impact factor: 3.630

9.  What every psychiatrist should know about PANDAS: a review.

Authors:  Germana Moretti; Massimo Pasquini; Gabriele Mandarelli; Lorenzo Tarsitani; Massimo Biondi
Journal:  Clin Pract Epidemiol Ment Health       Date:  2008-05-21

Review 10.  Alterations in the Nervous System and Gut Microbiota after β-Hemolytic Streptococcus Group A Infection-Characteristics and Diagnostic Criteria of PANDAS Recognition.

Authors:  Jacek Baj; Elżbieta Sitarz; Alicja Forma; Katarzyna Wróblewska; Hanna Karakuła-Juchnowicz
Journal:  Int J Mol Sci       Date:  2020-02-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.